Back to UBS Group AG UBS Group AG

WINTWINT
3 quarters

Position history for UBS Group AGUBS Group AG's holdings in Windtree Therapeutics, Inc.

UBS Group AG previously held 0 shares of WINT (Windtree Therapeutics, Inc.), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$36,244

Total Shares Change

-28,765

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.07
0
2025-Q2
Decreased
22
-99.9%
$110.0%$0.45
0
2025-Q1
New
28,765
-
$36,2440.0%$1.56
30

Other major holders of WINT: MORGAN STANLEY, JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used